From the Editor

A wise aproach to bipolar depression

Author and Disclosure Information

 

Most of us care for patients with bipolar disorder and face this problem regularly: We start an antidepressant for breakthrough depressive symptoms, and the patient responds. How long do we continue the antidepressant?

In this issue, Robert M. Post, MD, head of the Bipolar Collaborative Network, summarizes the published literature—and some very recent unpublished reports—related to this question and makes systematic recommendations. I won’t attempt to summarize his carefully considered conclusions, but I would like to highlight his two-pronged” approach:

  • conservative treatment—no change in medication—when the patient remains well
  • aggressive—if not radical—treatment when the illness course remains problematic.

I cannot help but reflect that these recommendations—wise advice for many clinical problems—echo the Hippocratic principles of “first, do no harm” and “extreme illnesses require extreme remedies.” Although, thank goodness, today’s medical treatments bear no resemblance to those used in Hippocrates’ time, our wisdom still bears a resemblance to his.

Conscientious physicians aspire to keep up with the latest literature while growing in professional wisdom. Helping us with those challenging tasks is Current Psychiatry’s goal.

Recommended Reading

Tips for using lithium in bipolar disorder
MDedge Psychiatry
Omega-3 fatty acids: Do ‘fish oils’ have a therapeutic role in psychiatry?
MDedge Psychiatry
Intramuscular olanzapine: Treating acute agitation in psychosis and bipolar mania
MDedge Psychiatry
TMP bipolar algorithms: Not ‘cookbook’ medicine
MDedge Psychiatry
Bipolar I vs. Bipolar II
MDedge Psychiatry
Using lithium in bipolar disorder
MDedge Psychiatry
Lithium in bipolar disorder
MDedge Psychiatry
Bipolar treatment update: Evidence is driving change in mania, depression algorithms
MDedge Psychiatry
Bipolar maintenance: Are atypical antipsychotics really ‘mood stabilizers’?
MDedge Psychiatry
Olanzapine/fluoxetine combination: Evidence for using the first treatment indicated for bipolar depression
MDedge Psychiatry